This is a routine strategic update with no financial data — no immediate trading catalyst. Monitor future 6-K or 20-F filings for evidence of U.S. revenue generation or operational milestones from WBT.
Price Chart
Executive Summary
WORK Medical Technology Group filed a 6-K announcing the establishment of a wholly-owned U.S. subsidiary, Work Bio Technologies Ltd (WBT), in Nevada on April 22, 2026, and its participation as a partner and exhibitor at the 2026 CBA-China Annual Conference. The filing contains no financial data, guidance, or material contracts — it is a routine corporate update on strategic expansion efforts.
Key Facts
- Established wholly-owned U.S. subsidiary Work Bio Technologies Ltd (WBT) in Nevada on April 22, 2026.
- WBT is intended to serve as the company's primary operational platform in the United States.
- CEO Shuang Wu serves as President, Secretary, Treasurer, and Director of WBT.
- Company participated as a partner and exhibitor at the 2026 CBA-China Annual Conference held May 8-10, 2026 in Wuxi, China.
- No financial figures, revenue, earnings, or guidance were disclosed in the filing.
Financial Impact
No financial impact disclosed; subsidiary establishment is a strategic organizational change with no immediate revenue or cost figures provided.
Risk Factors
- U.S. subsidiary may not generate material revenue or operational benefits as projected.
- Forward-looking statements about global expansion are aspirational and subject to execution risk.
- No financial commitments or capital allocation details were provided for the subsidiary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-065784 |
| Document: ea029376901ex99-2.htm | 0001213900-26-065784 |
| Document: ea029376901ex99-1.htm | 0001213900-26-065784 |
| Document: 0001213900-26-065784-index-headers.html | 0001213900-26-065784 |
| Document: 0001213900-26-065784-index.html | 0001213900-26-065784 |
| Document: 0001213900-26-065784.txt | 0001213900-26-065784 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 12, 2026 19w ago | 3 | $0.0753 $0.0198 | ▼ −73.71% | ▼ −75.06% | $1.16 (+1445.42%) |
Jun 8, 2026 20w ago | 3 | $0.1005 $0.0202 | ▼ −79.90% | ▼ −81.89% | $1.16 (+1057.91%) |
Jun 5, 2026 20w ago | 6-K | $0.1001 $0.0196 | ▼ −80.42% | ▼ −81.26% | $1.16 (+1062.54%) |
Jun 3, 2026 20w ago | 3 | $10.70 $2.21 | ▼ −79.35% | ▼ −78.35% | $1.16 (−89.12%) |
Jun 2, 2026 20w ago | 3 | $10.40 $2.12 | ▼ −79.62% | ▼ −78.05% | $1.16 (−88.81%) |
May 28, 2026 21w ago | 3 | $10.10 $2.22 | ▼ −78.02% | ▼ −74.87% | $1.16 (−88.48%) |
Apr 15, 2026 27w ago | 6-K | $117.00 $130.00 | ▲ +11.11% | ▲ +4.48% | $1.16 (−99.01%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers